Global Patent Index - EP 1317527 A2

EP 1317527 A2 20030611 - CELLULAR GENES INVOLVED IN ONCOGENESIS, PRODUCTS OF SAID GENES AND THEIR DIAGNOSTIC AND THERAPEUTIC USES

Title (en)

CELLULAR GENES INVOLVED IN ONCOGENESIS, PRODUCTS OF SAID GENES AND THEIR DIAGNOSTIC AND THERAPEUTIC USES

Title (de)

ZELLGENE WELCHE BEI DER ONKOGENESE EINE ROLLE SPIELEN, PRODUKTE DIESER GENE UND DEREN THERAPEUTISCHE UND DIAGNOSTISCHE VERWENDUNG

Title (fr)

GENES CELLULAIRES IMPLIQUES DANS L'ONCOGENESE, LES PRODUITS DE CES GENES ET LEURS APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES

Publication

EP 1317527 A2 20030611 (FR)

Application

EP 01963042 A 20010731

Priority

  • FR 0102509 W 20010731
  • FR 0011826 A 20000915
  • US 29292001 P 20010523

Abstract (en)

[origin: WO0222777A2] The invention concerns the identification of cellular genes involved in oncogenesis, by insertional mutagenesis of the hepatitis B virus. Besides novel genes (including a gene of the MCM family), the invention further concerns the involvement of TRAP-150, SERCA-1, hTERT, CCT7, NMP 84p, TRKB, TRUP, ST3GalVI, and IP3R1 genes in cancerology.

IPC 1-7

C12N 1/00

IPC 8 full level

A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); C07K 16/40 (2006.01); C12N 9/12 (2006.01); C12N 15/12 (2006.01); A61K 38/00 (2006.01)

CPC (source: EP US)

A61P 35/00 (2017.12 - EP); C07K 14/47 (2013.01 - EP US); C07K 14/705 (2013.01 - EP US); C07K 16/18 (2013.01 - EP US); C07K 16/40 (2013.01 - EP US); C12N 9/1205 (2013.01 - EP US); C12N 9/1241 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); A61K 2039/53 (2013.01 - EP US)

Citation (search report)

See references of WO 0222777A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0222777 A2 20020321; WO 0222777 A3 20021024; EP 1317527 A2 20030611; US 2004072185 A1 20040415

DOCDB simple family (application)

FR 0102509 W 20010731; EP 01963042 A 20010731; US 38037403 A 20030811